237 related articles for article (PubMed ID: 34375498)
1. The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasia.
Morote J; Schwartzmann I; Celma A; Roche S; de Torres IM; Mast R; Semidey ME; Regis L; Santamaria A; Planas J; Trilla E
BJU Int; 2022 May; 129(5):627-633. PubMed ID: 34375498
[TBL] [Abstract][Full Text] [Related]
2. Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings.
Morote J; Schwartzman I; Borque A; Esteban LM; Celma A; Roche S; de Torres IM; Mast R; Semidey ME; Regis L; Santamaría A; Planas J; Trilla E
Urol Oncol; 2021 Jul; 39(7):432.e11-432.e19. PubMed ID: 33160846
[TBL] [Abstract][Full Text] [Related]
3. The current value of histological findings in negative prostate biopsies to predict the future risk of clinically significant prostate cancer.
Schwartzmann I; Celma A; Regis L; Planas J; Roche S; de Torres IM; Semidey ME; Morote J
Actas Urol Esp (Engl Ed); 2021; 45(6):447-454. PubMed ID: 34140257
[TBL] [Abstract][Full Text] [Related]
4. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
[TBL] [Abstract][Full Text] [Related]
5. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
6. Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?
Exterkate L; Wegelin O; Barentsz JO; van der Leest MG; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; van Melick HHE; Somford DM
Eur Urol Oncol; 2020 Apr; 3(2):216-223. PubMed ID: 31239236
[TBL] [Abstract][Full Text] [Related]
7. How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series.
Barletta F; Stabile A; Mazzone E; Brembilla G; Sorce G; Pellegrino F; Scuderi S; Cannoletta D; Cirulli GO; Cucchiara V; Gandaglia G; De Cobelli F; Montorsi F; Briganti A
Urol Oncol; 2022 Mar; 40(3):103.e17-103.e24. PubMed ID: 34688534
[TBL] [Abstract][Full Text] [Related]
8. Atypical small acinar proliferation and two or more cores of high-grade intraepithelial neoplasia on a previous prostate biopsy are significant predictors of cancer during a transperineal template-guided saturation biopsy aimed at sampling one core for each 1 mL of prostate volume.
Nakai Y; Tanaka N; Miyake M; Hori S; Tatsumi Y; Morizawa Y; Fujii T; Konishi N; Fujimoto K
Res Rep Urol; 2017; 9():187-193. PubMed ID: 29034221
[TBL] [Abstract][Full Text] [Related]
9. Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: a 12 months analysis after three consecutive prostate biopsies.
De Nunzio C; Albisinni S; Cicione A; Gacci M; Leonardo C; Esperto F; Tubaro A
Arch Ital Urol Androl; 2013 Jun; 85(2):59-64. PubMed ID: 23820650
[TBL] [Abstract][Full Text] [Related]
10. Do all patients with suspicious prostate cancer need Multiparametric Magnetic Resonance Imaging before prostate biopsy?
Teixeira Anacleto S; Neves Alberto J; Carvalho Dias E; Sousa Passos P; Cerqueira Alves M
Arch Ital Urol Androl; 2022 Mar; 94(1):32-36. PubMed ID: 35352522
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325
[TBL] [Abstract][Full Text] [Related]
12. A 4K score/MRI-based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer.
Wagaskar VG; Sobotka S; Ratnani P; Young J; Lantz A; Parekh S; Falagario UG; Li L; Lewis S; Haines K; Punnen S; Wiklund P; Tewari A
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1357. PubMed ID: 33661541
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MR can identify high grade prostatic intraepithelial neoplasia (HGPIN) lesions and predict future detection of prostate cancer in men with a negative initial prostate biopsy.
Dwivedi DK; Kumar R; Bora GS; Sharma S; Thulkar S; Gupta SD; Jagannathan NR
Magn Reson Imaging; 2016 Oct; 34(8):1081-6. PubMed ID: 27211254
[TBL] [Abstract][Full Text] [Related]
14. Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer Detection.
Morote J; Picola N; Muñoz-Rodriguez J; Paesano N; Ruiz-Plazas X; Muñoz-Rivero MV; Celma A; Manuel GG; Miró B; Servian P; Abascal JM
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397430
[TBL] [Abstract][Full Text] [Related]
15. Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series.
Pellegrino F; Stabile A; Mazzone E; Sorce G; Barletta F; De Angelis M; Brembilla G; Gandaglia G; De Cobelli F; Montorsi F; Briganti A
Prostate; 2022 Sep; 82(12):1170-1175. PubMed ID: 35538401
[TBL] [Abstract][Full Text] [Related]
16. Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score.
Pellegrino F; Stabile A; Sorce G; Quarta L; Robesti D; Cannoletta D; Cirulli G; Barletta F; Scuderi S; Mazzone E; de Angelis M; Brembilla G; De Cobelli F; Salonia A; Montorsi F; Briganti A; Gandaglia G
Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37865591
[TBL] [Abstract][Full Text] [Related]
17. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
Delatour NL; Mai KT
Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
[TBL] [Abstract][Full Text] [Related]
18. Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial.
Exterkate L; Wegelin O; Barentsz JO; van der Leest MG; Kummer JA; Vreuls W; de Bruin PC; Witjes JA; van Melick HHE; Somford DM
BJU Int; 2023 Mar; 131(3):313-320. PubMed ID: 35993590
[TBL] [Abstract][Full Text] [Related]
19. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
[TBL] [Abstract][Full Text] [Related]
20. Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category.
Morote J; Campistol M; Triquell M; Celma A; Regis L; de Torres I; Semidey ME; Mast R; Santamaria A; Planas J; Trilla E
Eur Urol Open Sci; 2022 Mar; 37():38-44. PubMed ID: 35243388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
